FDA Label for Histex-dm New Formulation

View Indications, Usage & Precautions

Histex-dm New Formulation Product Label

The following document was submitted to the FDA by the labeler of this product Allegis Pharmaceuticals, Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Other



Drug Facts


Otc - Purpose



Active ingredients (in each 5 mL teaspoonful)Purpose
Dextromethorphan HBr 20 mgCough Suppressant
Pseudoephedrine HCI 30 mgNasal Decongestant
Triprolidine HCl 2.5 mgAntihistamine

Uses



temporarily relieves these symptoms due to common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

  • cough due to minor throat or bronchial irritation
  • runny nose
  • sneezing
  • itching of the nose or throat
  • itchy, watery eyes
  • nasal congestion
  • reduces swelling of nasal passages

Warnings



Do not exceed recommended dosage.


Do Not Use This Product



  • If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product.

Ask A Doctor Before Use If You Have



  • a breathing problem such as emphysema or chronic bronchitis
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • glaucoma
  • a persistent or chronic cough such occurs with smoking, asthma, chronic bronchitits, or emphysema
  • a cough that occurs with too much phlegm (mucus)
  • trouble urinating due to an enlarged prostate gland
  • Ask a doctor before use if you are taking sedatives or tranquilizers


When Using This Product



  • excitability may occur, especially in children
  • may cause drowsiness
  • alcohol, sedatives and tranquilizers may increase the drowsiness effect
  • avoid alcoholic beverages
  • use caution when driving a motor vehicle or operating machinery

Stop Use And Ask A Doctor If



  • nervousness, dizziness, or sleeplessness occur
  • cough or nasal congestion persists for more than 1 week, tends to recur or is accompanied by a fever, rash or persistent headache.
  • new symptoms occur
  • These could be signs of a serious condition.


Otc - Pregnancy Or Breast Feeding



If pregnant or breast-feeding, ask a health professional before use.


Otc - Keep Out Of Reach Of Children



Keep out of the reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.


Directions



Do not exceed recommended dosage.

AGEDOSE
Adults and Children 12 years of age and older:1 teaspoonful (5 mL) every 4 hours, not to exceed 4 teaspoonfuls (20 mL) in 24 hours, or as directed by a doctor
Children 6 to under 12 years of age½ teaspoonful (2.5 mL) every 4 hours, not to exceed 2 teaspoonfuls (10 mL) in 24 hours, or as directed by a doctor.
Children under 6 years of ageConsult a doctor

Other Information



Store at 15°-30° C (59°-86° F).

Tamper evident by foil seal under cap. Do not use if foil seal is missing or broken.


Inactive Ingredients



Citric Acid, Glycerin, Grape Flavor, Propylene Glycol, Purified Water, Sodium Bensoate, Soduim Citrate, Sodium Saccharin, Sorbitol Solution.


Questions? Comments?



Call 1-866-633-9033.

Manufactured for: Allegis Pharmaceuticals, Inc.

Canton MS 39046

www.allegispharma.com

Rev. 01/2025


Principal Display Panel - 473 Ml Bottle Label



NDC 28595-310-16

Antihistamine - Nasal Decongestant - Cough Suppressant

HISTEX™-DM New Formulation
Syrup

Each teaspoonful (5 mL)

contains:


Dextromethorphan HBr 20 mg

Pseudoephedrine HCI 30mg

Triprolidine HCl 2.5 mg

Sugar-Free - Dye Free - Alcohol Free

Grape Flavor

16 fl oz (473 mL)


* Please review the disclaimer below.